197 related articles for article (PubMed ID: 11751863)
1. Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II.
Hatters DM; Minton AP; Howlett GJ
J Biol Chem; 2002 Mar; 277(10):7824-30. PubMed ID: 11751863
[TBL] [Abstract][Full Text] [Related]
2. The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II.
Hatters DM; Lindner RA; Carver JA; Howlett GJ
J Biol Chem; 2001 Sep; 276(36):33755-61. PubMed ID: 11447233
[TBL] [Abstract][Full Text] [Related]
3. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops.
Hatters DM; MacPhee CE; Lawrence LJ; Sawyer WH; Howlett GJ
Biochemistry; 2000 Jul; 39(28):8276-83. PubMed ID: 10889036
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways.
Griffin MD; Mok ML; Wilson LM; Pham CL; Waddington LJ; Perugini MA; Howlett GJ
J Mol Biol; 2008 Jan; 375(1):240-56. PubMed ID: 18005990
[TBL] [Abstract][Full Text] [Related]
5. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis.
Wilson LM; Mok YF; Binger KJ; Griffin MD; Mertens HD; Lin F; Wade JD; Gooley PR; Howlett GJ
J Mol Biol; 2007 Mar; 366(5):1639-51. PubMed ID: 17217959
[TBL] [Abstract][Full Text] [Related]
6. Sub-micellar phospholipid accelerates amyloid formation by apolipoprotein C-II.
Hatters DM; Lawrence LJ; Howlett GJ
FEBS Lett; 2001 Apr; 494(3):220-4. PubMed ID: 11311244
[TBL] [Abstract][Full Text] [Related]
7. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.
Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW
J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062
[TBL] [Abstract][Full Text] [Related]
8. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain.
Chiti F; Bucciantini M; Capanni C; Taddei N; Dobson CM; Stefani M
Protein Sci; 2001 Dec; 10(12):2541-7. PubMed ID: 11714922
[TBL] [Abstract][Full Text] [Related]
9. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
[TBL] [Abstract][Full Text] [Related]
10. Macromolecular crowding modulates the kinetics and morphology of amyloid self-assembly by β-lactoglobulin.
Ma B; Xie J; Wei L; Li W
Int J Biol Macromol; 2013 Feb; 53():82-7. PubMed ID: 23148946
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.
Hughes E; Burke RM; Doig AJ
J Biol Chem; 2000 Aug; 275(33):25109-15. PubMed ID: 10825171
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II.
Ryan TM; Howlett GJ; Bailey MF
J Biol Chem; 2008 Dec; 283(50):35118-28. PubMed ID: 18852267
[TBL] [Abstract][Full Text] [Related]
13. Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.
McParland VJ; Kad NM; Kalverda AP; Brown A; Kirwin-Jones P; Hunter MG; Sunde M; Radford SE
Biochemistry; 2000 Aug; 39(30):8735-46. PubMed ID: 10913285
[TBL] [Abstract][Full Text] [Related]
14. The circularization of amyloid fibrils formed by apolipoprotein C-II.
Hatters DM; MacRaild CA; Daniels R; Gosal WS; Thomson NH; Jones JA; Davis JJ; MacPhee CE; Dobson CM; Howlett GJ
Biophys J; 2003 Dec; 85(6):3979-90. PubMed ID: 14645087
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation.
Srisailam S; Kumar TK; Rajalingam D; Kathir KM; Sheu HS; Jan FJ; Chao PC; Yu C
J Biol Chem; 2003 May; 278(20):17701-9. PubMed ID: 12584201
[TBL] [Abstract][Full Text] [Related]
16. Cross-linking and amyloid formation by N- and C-terminal cysteine derivatives of human apolipoprotein C-II.
Pham CL; Hatters DM; Lawrence LJ; Howlett GJ
Biochemistry; 2002 Dec; 41(48):14313-22. PubMed ID: 12450397
[TBL] [Abstract][Full Text] [Related]
17. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation.
Kim YS; Randolph TW; Manning MC; Stevens FJ; Carpenter JF
J Biol Chem; 2003 Mar; 278(12):10842-50. PubMed ID: 12529361
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-like fibril formation of co-chaperonin GroES: nucleation and extension prefer different degrees of molecular compactness.
Higurashi T; Yagi H; Mizobata T; Kawata Y
J Mol Biol; 2005 Sep; 351(5):1057-69. PubMed ID: 16054644
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for amyloid formation by plasma apolipoproteins: a review.
Hatters DM; Howlett GJ
Eur Biophys J; 2002 Mar; 31(1):2-8. PubMed ID: 12046894
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
